RELMADA THERAPEUTICS, INC. Balance Sheet
RLMD|1 years of annual SEC 10-K data (FY2013-FY2013)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity. All figures from audited SEC 10-K filings.
RELMADA THERAPEUTICS, INC. had $20,009 in total assets with negative shareholders' equity of $13,657 as of FY2013.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2013 |
|---|---|
| Current Assets | $18.5K |
| PP&E (Net) | $1.6K |
| Total Assets | $20.0K |
| Current Liabilities | $33.7K |
| Shareholders' Equity | -$13.7K |